Amarin Corp Plc (AMRN)

[couldbebetter]

Chris2125, Obviously AMRN will go forward with the promotion of Vascepa
as they go forward on the appeal. One never knows if something unexpected
out of left field occurs. Then, there is the Europe situation. Perhaps
that will be a potential catalyst for a BO. What is strange to me is the
lack of speculation or excitement over how Vascepa is not only a very
safe and effective Cardiovascular drug...but may ultimately play a role
in the treatment of some people who had the COVID-19 virus. How many
of those people may think they have fully recovered who may have some
sort of residual inflammatory effect. Maybe COVID-19 accelerates the
inflammatory cascade that will smolder until at some point in the
future it fully ignites. "If" that turns out to be the case, Vascepa
(along with a statin) may be the best treatment option for such
patients. The important medical question is this: Does COVID-19
exposure result in a sustained increase in CRP levels? If the
answer turns out to be yes Vascepa may be a most important drug to
treat such a condition. (Not even on this board is this ever
discussed in any detail.) Vascepa may have a very bright future,
but not if JT insists on a GIA strategy.